Now that Novartis is buying AAA, I’m zeroing in on this potential pharma target By: MarketWatch November 01, 2017 at 10:11 AM EDT Neos Therapeutics rejected a buyout offer, but it may be acquired in the end, writes Nigam Arora. Read More >> Related Stocks: Apple Bellicum Pharmaceuticals Inc Bluebird Bio Gilead Sciences Neos Therapeutics Novartis Ag ADR Pdl Biopharma Inc Ziopharm Oncology IN